OSTX - Latest News
OS Therapies Incorporated (OSTX), operates in Healthcare / Biotechnology, trades on AMEX.
Market capitalization stands near $84.2M. Beta to the broader market is -1.34.
The article list below shows the most recent OSTX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent OSTX Headlines
OS Therapies Announces the Publication of Four Articles on OST-HER2 and Osteosarcoma in Drug Discovery World
newsfilecorp.com - May 29, 2026
The Company confirms that it will release 2. 5 year overall survival data from Phase 2b clinical trial OST-HER2 in the prevention or delay of recurren
OS Therapies to Attend Upcoming Medical, Financial and Industry Conferences
newsfilecorp.com - May 26, 2026
ASCO 2026: 2. 5-Year Overall Survival Data Jefferies Healthcare Conference: Partnering & Investor meetings BIO International Convention: Panel Partici
OS Therapies Reports First Quarter 2026 Financials and Provides Business Update
newsfilecorp.com - May 18, 2026
$5. 5 million financing that closed on April 2, 2026 together with $5.
OS Therapies to Announce First Quarter 2026 Financials on Monday, May 18, 2026
newsfilecorp.com - May 15, 2026
New York, New York and Rockville, Maryland--(Newsfile Corp. - May 15, 2026) - OS Therapies, Inc.
OS Therapies Appoints Industry Leader Dr. Craig Eagle as Chief Medical Advisor
newsfilecorp.com - May 14, 2026
Appointment strengthens medical, regulatory, and commercial leadership as Company prepares to complete early market access regulatory filings in the U
How News Affects OSTX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track OSTX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked OSTX news questions
- What is the latest OSTX news headline?
- The most recent OSTX headline (May 29, 2026) is "OS Therapies Announces the Publication of Four Articles on OST-HER2 and Osteosarcoma in Drug Discovery World". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the OSTX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What OSTX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual OSTX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.